The Life Science Effect

In this solo episode, Steve Vinson explores the rapidly evolving obesity drug market, highlighting insights from a recent Fierce Biotech power rankings article. He breaks down why Lilly and Novo Nordisk currently dominate, while examining the growing competitive field and what may determine the next wave of winners. The discussion focuses on the shift from breakthrough science to scalable executio...

In this episode, Steve Vinson examines the sustained wave of biopharma manufacturing investment in North America and challenges the idea that tariffs were the primary driver. He explores the deeper forces reshaping the industry, including supply chain resilience, demand for complex biologics, and global uncertainty. The discussion focuses on what is actually being built, why it matters, and what t...

In this solo episode, Steve Vinson explores the confusing and often frustrating reality of prescription drug pricing in the United States. Through a personal story, he unpacks how the same medication can cost dramatically different amounts depending on how and where it is accessed. The episode highlights a deeper issue beyond cost—lack of transparency—and what that means for trust in the healthcar...

In this episode, Steve Vinson reflects on a recent Indianapolis Business Journal article about Ossium Health and its approach to bone marrow banking. He explores how innovation in life sciences often comes not from new discoveries, but from improving systems, logistics, and execution. The discussion highlights why infrastructure and operational excellence are becoming critical to the future of med...

Artificial intelligence is moving fast—but in regulated life science environments, speed without trust is a non‑starter. In this episode of The Life Science Effect , host Steven Vinson reacts to a recent EY article on AI validation in pharmaceutical and biotech settings and explores a fascinating question: Can AI actually be used to validate other AI systems? Steven walks through how regulators ar...

In this episode, host Steve Vinson dives into one of the most futuristic — yet rapidly emerging — trends in life sciences: transportable and point‑of‑care pharmaceutical manufacturing. After discovering a compelling ISPE article, Steve explores how modular clean rooms, distributed manufacturing models, and space‑ready production units are reshaping the future of medicine. From personalized tablet...

In this episode, Steve Vinson dives into a provocative article by US Senator Todd Young, exploring the shifting landscape of global biotech innovation. With China's rapid advances—highlighted by a breakthrough lung cancer drug—Steve analyzes the factors behind America's waning leadership, from fragmented policy and regulatory uncertainty to funding challenges and talent migration. Drawing on his o...

Step into the future of pharmaceutical and medical device innovation with Steve on The Life Science Effect. In this episode, Steve explores the transformative power of Pharma 4.0 and Validation 4.0, drawing insights from two thought-provoking blog posts by Robert Perks of Performance Validation. Discover how digital-first strategies, artificial intelligence, and continuous monitoring are reshaping...

In this thought-provoking Active Ingredient episode, host Steve Vinson tackles a leadership paradigm that's challenging everything he thought he knew about accountability. Inspired by Sheila Rohra's Forbes article on breaking people silos, Steve dives deep into the tension between traditional "one person accountable" thinking and the emerging concept of shared accountability across teams. Drawing...

Meet Raul Zavaleta, the visionary engineer whose innovations fundamentally transformed how clinical trials collect and process data. In this captivating conversation, Raul shares the incredible journey from UCLA graduate to co-founder of what became Covance - one of the world's largest clinical research organizations. Discover how a simple frustration with keypunch cards led to revolutionary solut...

In this episode, Steve reads and discusses an article by Jason Bork titled "Alzheimer's, a Disease to be Forgotten?," featured in the Indianapolis Business Journal's special supplement, Biofutures. Steve shares his off-the-cuff impressions and insights on Bork's article, which discusses the current state of Alzheimer's research, the challenges of clinical trials, and the progress made with recent...

This is the second installment of Active Ingredient. I read an article and answer a few questions about it. It's shorter than the regular episodes. I try to get to the key points of the article - the active ingredient. This episode is my off the cuff reaction to an article in the Indianapolis Business Journal by Daniel Lee, Animal-health startup BiomEdit advances poultry antibody, lands $20M in fu...

Welcome to a new feature I am calling Active Ingredient. I read an article and answer a few questions about it. It's shorter than the regular episodes. I try to get to the key points of the article - the active ingredient. This episode is my off the cuff reaction to an article in Cure by Ryan Flinn called Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty. Here is a link to the article:...

In this mid-2025 update,  The Life Science Effect  explores the latest trends in pharma and medical devices—from regulatory upheaval under RFK Jr. and Dr. Makary to continued momentum in U.S. drug manufacturing. Learn how industry leaders are navigating clinical trial delays, FDA uncertainty, and global GLP-1 market expansion. Full transcript: Hey, everybody. Steve again, welcome back to the Life...

Production Note: Since this episode was recorded, Robert F. Kennedy, Jr. was confirmed as the head of HHS. Steve didn't know that at the time but it was a pretty good bet, so the analysis holds up. In this topical episode of  The Life Science Effect , Steve explores the uncertainties facing the life sciences industry under the new U.S. administration. He discusses the potential impact of leadershi...

In this timely and thought-provoking episode, Steve Vinson discusses the current landscape of diversity, equity, and inclusion (DEI) in the corporate world amid increasing political and business pushback. He reflects on recent headlines about major corporations rolling back DEI initiatives and contrasts that with companies like Costco and JP Morgan Chase, which are standing firm in their commitmen...

In this episode of the Life Science Effect, host Steve Vinson interviews Denise Bachman, Chief Operating Officer of BPM Associates. Denise shares insights into BPM Associates, a life sciences consultancy known for its unique approach and core values. She discusses her journey as a project manager and the importance of building a supportive company culture. Denise emphasizes the significance of hig...

Steve Vinson interviews Jeremy Opperman, the founder of BPM Associates. Jeremy shares his journey from growing up in a small business environment to starting his own company, BPM Associates, which specializes in life science project delivery. He emphasizes the importance of quality and people-focused relationships in his business. Jeremy also discusses the challenges and successes of building BPM...

In Season 2, Episode 3 of *The Life Science Effect*, Steve Vinson discusses BPM Associates' work. He explains BPM's core purpose and values—supporting people, fostering teamwork, and reducing turnover in the life sciences industry. Through personal stories, Steve illustrates the challenge of defining "what we do" in simple terms and describes BPM's approach to managing projects in pharmaceuticals,...

Host Steve Vinson continues exploring BPM Associates' core philosophy, following up on Simon Sinek's idea of starting with "why." In Episode 1, Steve shared why BPM does what it does—now, he turns to "how" they do it. Before diving into the business side, Steve shares a humorous and mostly true story about his recovery from outpatient surgery, which highlights the value of a great work environment...

In late 2021, the COO, founder, and CEO of BPM Associates gathered to do their annual planning. They decided that they needed a new vision statement that would resonate with their core ideology. They watched Simon Sinek's TED Talk on starting with "why" and realized that people don't buy from BPM or work for BPM because of what they do, but because of why they do it. They decided to focus on doing...

We're back! In this trailer, Steve explains why it has been so long, how we can have a Season 2 when there wasn't really a Season 1, and what you can expect from this season of the show. Music: Acid Jazz-Kevin MacLeod used under the Creative Commons Attribution 4.0 International License Acoustic Motivation-Corna Media used under the Creative Commons Attribution 4.0 International License

I've heard it said that culture beats strategy. I believe that. I also believe culture beats tactics and process and procedure and technique. In this episode (another solo episode), I will relate a recent story in which I had the chance to stand up and reinforce the safety culture of my client. It may not be for everybody. It may not be "life science" specific. That's okay. Not to worry. Life Scie...

What Does It Take To Succeed As A Bioentrepreneur? Source: Life Science Leader By Karl Schmieder Steve continues the discussion of how to transition into the startup world. The context is an article from a while back that still has relevant lessons for today. Also referenced in this episode: EP. 455 — RICH KARLGAARD Maybe You're a Late Bloomer. It's More Possible Than Ever Now to Flourish Later in...

Steve is solo this week. He decided to give his thoughts about an article in Life Science Leader - From Academia To Pharma CEO: Challenges and Lessons Learned by Graham Kelly Be sure and visit our presenting sponsor: BPM Associates